University of Pennsylvania - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

University of Pennsylvania - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Pennsylvania - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
University of Pennsylvania - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
64 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, criminology, fine arts, finance, operations and information management, telecommunications, theatre arts, and visual studies, among others. Its schools include school of arts and sciences, school of dental medicine, school of design, school of engineering and applied science, school of medicine and school of nursing.

University of Pennsylvania - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a

  
Source:
Document ID
GDPH67297D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents25
  List of Tables42
  List of Figures61
University of Pennsylvania, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201662
University of Pennsylvania, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201681
University of Pennsylvania, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201691
University of Pennsylvania, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016102
University of Pennsylvania, Medical Devices Deals, 2010 to YTD 2016121
University of Pennsylvania, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016133
University of Pennsylvania, Pharmaceuticals &Healthcare, Deal Details1644
  Partnerships161
    Liquid Biotech Enters into Research Agreement with University of Pennsylvania161
    Celgene Enters into Co-Development Agreement with Abramson Cancer Center171
    Bluepen Biomarkers Enters into Agreement with University of Pennsylvania181
    Biogen Enters into Co-Development Agreement with University of Pennsylvania192
    Seres Therapeutics Enters into Agreement with University of Pennsylvania211
    Audentes Therapeutics Enters into Co-Development with University of Pennsylvania221
    Genisphere Enters into Research Agreement with University of Pennsylvania231
    NeuroVive Pharma Enters into Research Agreement with University of Pennsylvania241
    Johnson &Johnson Consumer Enters into Research Agreement with University of Pennsylvania251
    Janssen Pharma Enters into Agreement with University of Pennsylvania261
    Lightlake Therapeutics Enters into Agreement with University of Pennsylvania271
    Epic Sciences Partners with Abramson Cancer Center281
    BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania291
    PTC Therapeutics Enters into Agreement with University of Pennsylvania301
    CCFA Enters into Research Agreement with Penn Med and Nestle Health Science311
    Dimension Therapeutics Amends Research Agreement with University of Pennsylvania321
    Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania331
    PolyMedix Enters Into Co-Development Agreement With University of Pennsylvania341
    Takara Bio Enters Into Research Agreement With University of Pennsylvania351
  Licensing Agreements361
    Dimension Therapeutics Enters into Licensing Agreement with Perelman School of Medicine at the University of Pennsylvania361
    Regenxbio Enters into Licensing Agreement with University of Pennsylvania and University of Minnesota371
    Kythera Biopharma Enters into Licensing Agreement with University of Pennsylvania381
    Spark Therapeutics Enters into Licensing Agreement with University of Pennsylvania for Proviral Plasmids392
    Amyndas Pharma Enters into Licensing Agreement with University of Pennsylvania411
    Spark Therapeutics Enters into Licensing Agreement with University of Pennsylvania422
    Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania442
    Agios Pharma Enters Into Licensing Agreement With University of Pennsylvania461
    Novartis Enters Into Licensing Agreement With University of Pennsylvania For CART-19472
    Eqalix Enters Into Licensing Agreement With Drexel University, University of Pennsylvania And Children's Hospital of Philadelphia492
    ImmunoCellular Therapeutics Enters Into Licensing Agreement With University of Pennsylvania For Dendritic-Cell Production Technology511
    Advaxis Enters Into Licensing Agreement With University of Pennsylvania For ISG15521
    Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania532
    Advaxis Amends Its Licensing Agreement With University of Pennsylvania551
    Inovio Biomedical Expands Licensing Agreement With University Of Pennsylvania561
  Equity Offering571
    Tmunity Therapeutics Raises USD10 Million in Equity Financing571
  Asset Transactions581
    University Of Pennsylvania Sells Portion Of Royalty Interest In Juxtapid For US$55 Million581
  Acquisition591
    University of Pennsylvania Health System To Acquire Chester County Hospital591
University of Pennsylvania - Key Competitors601
Key Employees611
Locations And Subsidiaries622
  Head Office621
  Other Locations &Subsidiaries622
Appendix641
  Methodology641
  About GlobalData641
  Contact Us641
  Disclaimer641

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "University of Pennsylvania - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Pennsylvania-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17177>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). University of Pennsylvania - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Pennsylvania-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17177>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research